Holen Sie sich die Stockscreener-App
4.22
1.20%
0.05
Handel nachbörslich:
4.21
-0.010
-0.24%
Schlusskurs vom Vortag:
$4.17
Offen:
$4.23
24-Stunden-Volumen:
1.35M
Relative Volume:
0.82
Marktkapitalisierung:
$406.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.49M
KGV:
-5.2163
EPS:
-0.809
Netto-Cashflow:
$-73.48M
1W Leistung:
-7.86%
1M Leistung:
-8.66%
6M Leistung:
+32.70%
1J Leistung:
-47.05%
1-Tages-Spanne:
$4.08
$4.355
1-Wochen-Bereich:
$3.97
$4.55
52-Wochen-Spanne:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
4.22 | 406.35M | 0 | -81.49M | -73.48M | -0.809 |
VRTX
Vertex Pharmaceuticals Inc
|
515.44 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
781.49 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.39 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
143.97 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.77 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-25 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-12-11 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Rezolute, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Rezolute: Initiating At Sell Despite Attempts To Rescue Ersodetug Following sunRIZE Upset - Seeking Alpha
Rezolute (RZLT) FDA Review Highlights Uncertain Path Amid Cash-F - GuruFocus
Rezolute says late-stage trial data for lead asset remains under FDA review - TradingView
Rezolute awaits FDA feedback on congenital HI treatment data By Investing.com - Investing.com Nigeria
Rezolute FDA Review Continues After Phase 3 sunRIZE Study Missed Primary Endpoint - Yahoo Finance
Rezolute (RZLT) Updates FDA Review of Phase 3 Data Amid Unprofitable Status - GuruFocus
Rezolute awaits FDA feedback on congenital HI treatment data - Investing.com
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism - The Manila Times
RZLT Q4'26 Earnings: EPS estimate is (0.15) USD - TradingView
FDA is still reviewing Rezolute’s experimental drug. No timeline is set. - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Rezolute Stock Price Forecast. Should You Buy RZLT? - StockInvest.us
Rezolute (RZLT) CCO sells stock to cover RSU taxes - Stock Titan
RZLT Q4'26 Earnings: revenue estimate is 0 USD - tradingview.com
Rezolute (RZLT) Shares Decline 7% as Stock Approaches Key Support at $4.39Diagonal Spread Trade - vinanet.vn
Wedbush Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Rezolute, Inc.'s (NASDAQ:RZLT) Shift From Loss To Profit - simplywall.st
Balyasny Asset Management L.P. Reduces Stake in Rezolute Inc (RZ - GuruFocus
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Rezolute Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bank of New York Mellon Corp Sells 481,913 Shares of Rezolute, Inc. $RZLT - MarketBeat
Balyasny reports 4.84% Rezolute (RZLT) stake in Schedule 13G/A - Stock Titan
Rezolute, Inc. $RZLT Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Bank of America Corp (RZLT) discloses 1.2% Rezolute ownership in 13G/A - Stock Titan
Rezolute, Inc. (RZLT) gains 5.9% reported stake from Dellora Investments - Stock Titan
Rezolute Inc (RZLT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rezolute Inc (RZLT) Stock News Today - TradingKey
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The National Law Review
RZLT Q2 2026 Earnings: Loss Narrows 12.33% vs. Estimates; Shares Slip 3.28%Estimate Dispersion - vinanet.vn
Rezolute (RZLT) Pulls Back 5.4% as Biotech Volatility ResurfacesAggressive Growth Picks - vinanet.vn
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX) - The Globe and Mail
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - moomoo.com
RZLT|Rezolute Inc|Price:4.930|Chg%:-0.060 - TradingKey
RZLT|Rezolute Inc|Price:4.990| - TradingKey
Rezolute Inc (RZLT) Balance Sheet - TradingKey
Rezolute Inc (RZLT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rezolute Inc (RZLT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rezolute Inc (RZLT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rezolute Inc (RZLT) Institutional Confidence - TradingKey
Rezolute Inc (RZLT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rezolute Inc (RZLT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rezolute Inc (RZLT) Income Statement - tradingkey.com
Rezolute Inc (RZLT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times
Rezolute Management to Meet Investors Online July 28-29 - Stock Titan
Rezolute to join BTIG Virtual Biotechnology Con... - Pluang
Rezolute (RZLT) Q2 2026 Earnings: EPS Beat with 12.33% Surprise Amid No RevenuePeak Earnings Alert - dars.gov.et
Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans? - Moomoo
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Rezolute Inc. (RZLT) Edges Higher Amid Positive Momentum, Testing Key ResistanceVWAP Breakout - vinanet.vn
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):